14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.82 $2.49 Tuesday, 23rd Apr 2024 PRQR stock ended at $2.02. This is 1.00% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.52% from a day low at $1.99 to a day high of $2.12.
90 days $1.82 $2.69
52 weeks $1.11 $3.29

Historical ProQR Therapeutics N.V. prices

Date Open High Low Close Volume
Apr 23, 2024 $2.01 $2.12 $1.99 $2.02 176 095
Apr 22, 2024 $2.02 $2.10 $1.97 $2.00 102 028
Apr 19, 2024 $1.90 $2.07 $1.87 $1.99 132 609
Apr 18, 2024 $1.94 $2.05 $1.82 $1.86 182 493
Apr 17, 2024 $1.96 $2.04 $1.86 $1.90 197 815
Apr 16, 2024 $2.00 $2.07 $1.92 $2.00 214 921
Apr 15, 2024 $2.20 $2.20 $1.91 $2.05 319 415
Apr 12, 2024 $2.23 $2.31 $2.11 $2.20 124 891
Apr 11, 2024 $2.29 $2.31 $2.25 $2.30 35 505
Apr 10, 2024 $2.27 $2.39 $2.25 $2.26 306 926
Apr 09, 2024 $2.15 $2.46 $2.15 $2.39 211 141
Apr 08, 2024 $2.20 $2.25 $2.13 $2.13 254 803
Apr 05, 2024 $2.16 $2.22 $2.13 $2.21 85 430
Apr 04, 2024 $2.12 $2.20 $2.12 $2.18 113 429
Apr 03, 2024 $2.09 $2.18 $2.08 $2.13 73 292
Apr 02, 2024 $2.14 $2.21 $2.05 $2.10 131 554
Apr 01, 2024 $2.26 $2.26 $2.10 $2.19 165 619
Mar 28, 2024 $2.41 $2.47 $2.23 $2.29 106 239
Mar 27, 2024 $2.40 $2.42 $2.36 $2.38 38 917
Mar 26, 2024 $2.37 $2.49 $2.35 $2.40 47 245
Mar 25, 2024 $2.46 $2.49 $2.37 $2.39 154 705
Mar 22, 2024 $2.37 $2.42 $2.27 $2.38 249 434
Mar 21, 2024 $2.46 $2.52 $2.39 $2.40 101 459
Mar 20, 2024 $2.49 $2.59 $2.40 $2.47 155 001
Mar 19, 2024 $2.45 $2.64 $2.37 $2.51 211 966
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT